0001209191-19-037713.txt : 20190618
0001209191-19-037713.hdr.sgml : 20190618
20190618163848
ACCESSION NUMBER: 0001209191-19-037713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190614
FILED AS OF DATE: 20190618
DATE AS OF CHANGE: 20190618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hochberg Elaine
CENTRAL INDEX KEY: 0001703059
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 19904017
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPAEUTICS
STREET 2: 55 CAMBRIDGE PKWY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-14
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001703059
Hochberg Elaine
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
1
0
0
0
Stock Option (right to buy)
22.74
2019-06-14
4
A
0
26400
0.00
A
2029-06-13
Common Stock
26400
26400
D
The shares vest over a four year period in equal annual installments beginning on June 14, 2019.
/s/ Jeffrey Goldberg, Attorney-in-Fact
2019-06-17